LeMaitre Vascular (NASDAQ: LMAT) is a medical device company that develops, manufactures, and sells specialty devices used in vascular surgery. Revenue comes from direct sales of single-use and implantable products to hospitals and vascular surgeons, with a transactional model tied to procedure volume. The filing does not provide sufficient excerpt detail to specify segment revenue percentages, exact product revenue figures, geographic mix, named competitors, or unit economics for FY2025. Based solely on the available filing excerpts, LeMaitre Vascular is incorporated in the United States and files as a well-known seasoned issuer with the SEC as of the 10-K filed February 26, 2026 (accession 0001193125-26-073360), covering the fiscal year ended December 31, 2025. Further specifics on revenue, headcount, product lines, market position, and leadership are not supported by the provided excerpts and are therefore omitted.

Source: SEC 10-K, filed 2026-02-26

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Alphatec Holdings Inc Butterfly Network Inc Cryoport Inc Paragon 28, Inc. Varex Imaging Corp Treace Medical Concepts, Inc Transmedics Group Inc